A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the food containing the polyphenols in Ashitaba (Angelica keiskei)

A double-blind, randomized, placebo-controlled clinical study to investigate the effect of the food containing the polyphenols in Ashitaba (Angelica keiskei) - A clinical study to investigate the effect of the food containing polyphenols in Ashitaba

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023988

Enrollment

Registered

2016-09-10

Start date

2016-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The food containing the polyphenols in Ashitaba (Angelica keiskei), 12 weeks The food non-containing the polyphenols in Ashitaba (Angelica keiskei), 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Males and females equal to or more than 20 years and less than 65 years of age 2. Healthy males and females with no treatment 3. Subjects equal to or more than 25 and less than 30 kg/m^2 of BMI at the pre-study 4. Subjects who recognize the object and contents of the study and submit the written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects who have marked impairment of liver, kidney, heart, lung, endocrine, metabolism, nerve, or consciousness, or have DM 2. Subjects who regularly use drugs, health foods, supplements which are suggested causal relationship from the study 3. Subjects who have allergy related to the test foods 4. Subjects who donated 200 mL or more of blood within a month prior to the study. 5. Heavy dinkers or heavy smokers 6. Subjects whose eating habits are extremely irregular 7. Pregnant and lactating female, or who wish to get pregnant during the study period. 8. Subjects who are ineligible due to physician's judgment.

Design outcomes

Primary

Measure	Time frame
Visceral fat area, at 8 and 12 weeks after intake	—

Countries

Japan

Contacts

Public ContactTomita Shimpei

New drug research center, Inc. Clinical Research Dept.

s-tomita@ndrcenter.co.jp0123-34-0412

Outcome results